645
Participants
Start Date
May 21, 2012
Primary Completion Date
December 15, 2015
Study Completion Date
December 15, 2015
Infanrix-IPV data collection
Safety monitoring: recording of adverse events using diary cards and recording of serious adverse events using the latest version of Korea's Post-Marketing Surveillance Serious Adverse Event Reporting Form.
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY